Lv72
3440 积分 2022-02-18 加入
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
13天前
已完结
The complex patent situation regarding antibody Fc engineering
24天前
已完结
SAM-Competitive PRMT5 Inhibitor PF-06939999 Demonstrates Antitumor Activity in Splicing Dysregulated NSCLC with Decreased Liability of Drug Resistance
25天前
已完结
Exploring DNA Damage Repair Therapeutics in Prostate Cancer beyond BRCAness
1个月前
已完结
Controlled Self‐Assembly of Discrete Amphiphilic Oligourethanes with a Cascade Self‐Immolative Motif
1个月前
已完结
Design of cathepsin-sensitive linkers for tumor-selective bioconjugate drug delivery
2个月前
已完结
The role of hydrophilic linkers in next-generation antibody-drug conjugates
2个月前
已完结
Modular Synthesis of Dehydroprolines by an Energy‐Transfer Enabled Cloke‐Wilson Rearrangement
2个月前
已完结
Preventing HER2 degradation improves efficacy of trastuzumab deruxtecan
2个月前
已完结
Targeted inhibition of FBXL2 confers susceptibility of HER2-negative breast cancer to trastuzumab deruxtecan
2个月前
已完结
皖公网安备34019202002308
